Aviner Z, Henley W L, Okas S, Leopold I H
Diabetes. 1976 Dec;25(12):1106-9. doi: 10.2337/diab.25.12.1106.
Leucocyte-migration inhibition was to determine the state of hypersensitivity in 65 diabetic patients with different stages of retinopathy and 21 nondiabetic controls. About one third of the patients with simple or proliferative retinopathy exhibited significant leucocyte-migration inhibition of 0.2 mg/ml. protein concentration of uvreoretinal antigen. In contrast, only one of 15 patients with minimal retinopathy and none of the controls showed significant leucocyte-migration inhibition. Corneal and lenticular antigens did not evoke a cellular immune response in any of the tested individuals. These findings suggest that cell-mediated hypersensitivity to uveoretinal antigen may develop in diabetic patients with prolonged, progressive, simple or proliferative retinopathy.
采用白细胞游走抑制试验来测定65例不同阶段视网膜病变的糖尿病患者及21例非糖尿病对照者的超敏反应状态。约三分之一患有单纯性或增殖性视网膜病变的患者,在葡萄膜视网膜抗原蛋白浓度为0.2mg/ml时,表现出显著的白细胞游走抑制。相比之下,15例患有轻度视网膜病变的患者中只有1例,且对照组中无人表现出显著的白细胞游走抑制。角膜和晶状体抗原在任何受试个体中均未引发细胞免疫反应。这些发现表明,在患有长期、进行性、单纯性或增殖性视网膜病变的糖尿病患者中,可能会发生对葡萄膜视网膜抗原的细胞介导超敏反应。